Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma

Fig. 2

(A): Surviving fraction (SF) of U87 cells irradiated with 2–8 Gy and treated with xenon (Xe), memantine (Mem) or both (Xe + Mem). Error bars indicate 95% confidence interval. Significant reduction in SF was found for Xe starting at a dose of 4 Gy and for Xe + Mem starting at 2 Gy (*p < 0.05). (B): Linear-quadratic regression analysis. Error bars indicate standard error of mean. Data are given as means of at least three independent experiments and were normalised to plating efficiency. Non-normalized data are shown in the appendix (Supplementary Fig. 3)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us